Synergy Pharmaceuticals (FRA:S90) Pre-Tax Income : €-114.57 Mil (TTM As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Synergy Pharmaceuticals's pretax income for the three months ended in Sep. 2018 was €-28.63 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2018 was €-114.57 Mil. Synergy Pharmaceuticals's pretax margin was -300.85%.

During the past 12 years, Synergy Pharmaceuticals's highest Pretax Margin was -329.37%. The lowest was -1333.76%. And the median was -1333.76%.

Synergy Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Synergy Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Pre-Tax Income Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Pre-Tax Income

Get a 7-Day Free Trial

-45.35

-77.62

-107.87

-188.28

-189.57

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Pre-Tax Income	Get a 7-Day Free Trial															-41.00	-31.24	-29.28	-25.42	-28.63

Competitive Comparison of Synergy Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Pre-Tax Income falls into.

Synergy Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Synergy Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2017 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-187.758	+	3.667	+	-5.475	+	0	+	0
	=	-189.57

Synergy Pharmaceuticals's Pretax Income for the quarter that ended in Sep. 2018 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-25.374	+	-0.371	+	-2.887	+	0	+	-3.5527136788005E-15
	=	-28.63

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €-114.57 Mil.

Synergy Pharmaceuticals (FRA:S90) Pre-Tax Income Explanation

Synergy Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2018 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-28.632	/	9.517
	=	-300.85%

During the past 12 years, Synergy Pharmaceuticals's highest Pretax Margin was -329.37%. The lowest was -1333.76%. And the median was -1333.76%.

Synergy Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines